Hot Topics At WCBP: Accelerated PPQ, Multi-Attribute Methods, ID And Stability Testing, Surfactant Control
Executive Summary
Discussions about accelerating process performance qualification for breakthrough therapies attracted standing room-only participation during roundtable sessions at this year's Well-Characterized Biotechnology Products conference.
You may also be interested in...
Genentech's Ocrevus Manufacturing Process Still A Work In Progress
Genentech overcame objections from US FDA quality reviewers to win approval of Ocrevus for multiple sclerosis by adding release and stability testing and committing to resolving process control issues, while suspending plans to accelerate post-approval manufacturing changes.
‘Shadow’ Factory Challenges Continue For US FDA
Agency wants more information about API suppliers as it winds up case against KV Tech for hidden use of Dr. Reddy’s plant and seeks to find disappearing manufacturer of contaminated OTC eye drops.
US FDA, USP Raise Questions About Valisure’s Assertions Of Benzoyl Peroxide’s Benzene Risks
The US drug regulatory authority and standard-setting organization are evaluating the drug-screening venture’s findings regarding stability and potential carcinogenic risks associated with the widely used acne treatment, which includes Rx formulations.